Copenhagen, Denmark

Jesper Langholm Jensen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jesper Langholm Jensen: A Profile of Innovation in Milk-Clotting Technology

Introduction

Jesper Langholm Jensen is an esteemed inventor based in Copenhagen, Denmark. With a robust portfolio of three patents, he stands out in the field of dairy technology. His innovations primarily revolve around enhancing milk-clotting properties, significantly impacting the dairy industry.

Latest Patents

Jensen's most recent patents include his groundbreaking work on "Variants of chymosin with improved milk-clotting properties." This invention aims to refine the efficiency of chymosin, an essential enzyme in cheese production. The innovative variants disclosed in his patents promise to elevate the quality and yield of dairy products.

Career Highlights

Jesper Langholm Jensen is affiliated with Chr. Hansen A/S, a leading global company specializing in food ingredients and biotechnology. His research and development efforts at this esteemed company have played a key role in advancing dairy processing methods. His continuous contribution to the field showcases his dedication to innovation and excellence.

Collaborations

Throughout his career, Jensen has collaborated with notable colleagues, including Johannes Maarten Van Den Brink and Jonas Jacobsen. Their teamwork has been instrumental in fostering advancements in milk-clotting technology, reflecting the importance of collaboration in driving innovation.

Conclusion

Jesper Langholm Jensen's contributions to the dairy industry through his innovative patents highlight the significance of research and development in food technology. His commitment to improving milk-clotting properties sets a benchmark for future inventions in this vital area. As he continues to work alongside talented colleagues at Chr. Hansen A/S, the potential for further breakthroughs remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…